Nasdaq notifies 707 Cayman (JEM) of bid-price deficiency

Rhea-AI Filing Summary

707 Cayman Holdings Limited reported it received a Nasdaq notice that its shares no longer meet the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), based on closing bids from September 3 to October 16, 2025.

Nasdaq granted a 180‑day compliance period through April 15, 2026 to regain compliance. If unmet, the Company may qualify for an additional 180 days if it satisfies the market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market (except bid price) and provides written notice of plans to cure, including a potential reverse stock split. Otherwise, Nasdaq may notify the Company that its securities are subject to delisting.

The Company is evaluating options and intends to regain compliance, while noting there is no assurance of success. A related press release dated October 21, 2025 was furnished as Exhibit 99.1.

Positive

• None.

Negative

• Nasdaq minimum bid price deficiency under Rule 5550(a)(2) with delisting risk if compliance is not regained within the 180-day period ending April 15, 2026.

Insights

Equity listings and market structure analyst

Nasdaq flagged a $1 bid shortfall; 180 days to fix, with possible extension.

707 Cayman Holdings Limited disclosed a deficiency under Nasdaq Rule 5550(a)(2) after its stock closed below $1.00 over the referenced period. Nasdaq granted a 180‑day window ending April 15, 2026 for the bid to reach at least $1.00 for the required duration to regain compliance.

A second 180‑day period may be available if the company meets all other initial listing standards and the market value of publicly held shares, and provides written notice of its intent to cure, potentially via a reverse stock split. If eligibility criteria aren’t met or the bid price isn’t restored, Nasdaq may move toward delisting.

The company states it is evaluating options and intends to regain compliance, without assurance. Actual impact depends on share price performance and any corporate actions the company undertakes; timing beyond the stated dates is not indicated in the excerpt.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2025

Commission File Number 001-42688

707 Cayman Holdings Limited

(Exact name of registrant as specified in its charter)

Not Applicable

(Translation of Registrant’s Name Into English)

5/F., AIA Financial Centre 712 Prince Edward Road East San Po Kong, Kowloon, Hong Kong
(Address of principal executive offices)		(Zip Code)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

Yes ☐ No ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):

Nasdaq Minimum Bid Price Deficiency Letter

On October 17, 2025, 707 Cayman Holdings Limited (the “Company”) received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that based on the closing bid price of the Company for the period from September 3, 2025 to October 16, 2025, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share.

Nasdaq has provided the Company with a 180-calendar day compliance period, or until April 15, 2026, in which to regain compliance with Nasdaq continued listing requirement. In the event that the Company does not regain compliance in the compliance period, the Company may be eligible for an additional 180 calendar days, should the Company meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and is able to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. However, if it appears that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that the Company’s securities will be subject to delisting.

The Company is currently evaluating options to regain compliance and intends to timely regain compliance with Nasdaq’s continued listing requirement. Although the Company will use all reasonable efforts to achieve compliance with Rule 5550(a)(2), there can be no assurance that the Company will be able to regain compliance with that rule or will otherwise be in compliance with other Nasdaq continued listing requirement.

On October 21, 2025, the Company issued a press release discussing the receipt of the deficiency letter, which is filed as exhibit 99.1 to this Form 6-K.

2

Exhibits

99.1 Press Release on Receipt of Nasdaq Deficiency Letter dated October 21, 2025

3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	707 Cayman Holdings Limited
Date: October 21, 2025	By	/s/ Cheung Lui
		Cheung Lui
		Chief Executive Officer and Executive Director

4

FAQ

What did 707 Cayman Holdings Limited (JEM) disclose in this 6-K?

The company received a Nasdaq notice that it no longer meets the $1.00 minimum bid price requirement under Rule 5550(a)(2).

How long does JEM have to regain Nasdaq bid price compliance?

Nasdaq granted a 180-day period ending April 15, 2026 to regain compliance.

Can 707 Cayman (JEM) get more time beyond April 15, 2026?

A second 180-day period may be available if it meets other initial listing standards and gives written notice of its intent to cure, potentially via a reverse split.

What happens if JEM does not regain compliance?

Nasdaq may notify the company that its securities will be subject to delisting.

What steps might JEM take to regain compliance?

The company is evaluating options and referenced that a reverse stock split could be used if necessary.

Did 707 Cayman issue a press release about the notice?

Yes. A press release dated October 21, 2025 was furnished as Exhibit 99.1.